Recent years have witnessed significant advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as potential https://ammarxuef973453.ttblogs.com/18834880/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide